Arab Pharmaceuticals (ADCI)

Currency in EGP
139.00
-1.00(-0.71%)
Closed·
ADCI Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Earnings results expected in 11 days
ADCI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
138.00143.00
52 wk Range
40.58158.00
Key Statistics
Bid/Ask
138.65 / 140.00
Prev. Close
140
Open
141
Day's Range
138-143
52 wk Range
40.58-158
Volume
115.18K
Average Volume (3m)
64.28K
1-Year Change
241.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADCI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Arab Pharmaceuticals Company Profile

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

Employees
1148
Market
Egypt

Compare ADCI to Peers and Sector

Metrics to compare
ADCI
Peers
Sector
Relationship
P/E Ratio
10.5x10.9x−0.5x
PEG Ratio
0.100.080.00
Price/Book
3.0x2.2x2.6x
Price / LTM Sales
1.6x1.8x3.3x
Upside (Analyst Target)
-12.8%40.1%
Fair Value Upside
Unlock11.5%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 13.23%
Dividend Yield
3.00%
Industry Median 3.43%
Annualised payout
4.18
Paid annually
5-Years Growth
+21.92%
Growth Streak

Earnings

Latest Release
May 28, 2025
EPS / Forecast
8.21 / --
Revenue / Forecast
263.29M / --
EPS Revisions
Last 90 days

ADCI Income Statement

People Also Watch

4.39
RMDA
+1.39%
164.00
EGAL
+0.37%
131.76
MPCI
+7.93%

FAQ

What Stock Exchange Does Arab Pharma Trade On?

Arab Pharma is listed and trades on the Egypt Stock Exchange stock exchange.

What Is the Stock Symbol for Arab Pharma?

The stock symbol for Arab Pharma is "ADCI."

What Is the Arab Pharma Market Cap?

As of today, Arab Pharma market cap is 1.67B.

What Is Arab Pharma's Earnings Per Share (TTM)?

The Arab Pharma EPS (TTM) is 13.23.

When Is the Next Arab Pharma Earnings Date?

Arab Pharma will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is ADCI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Arab Pharma Stock Split?

Arab Pharma has split 5 times.

How Many Employees Does Arab Pharma Have?

Arab Pharma has 1148 employees.

What is the current trading status of Arab Pharma (ADCI)?

As of 17 Aug 2025, Arab Pharma (ADCI) is trading at a price of 139.00, with a previous close of 140.00. The stock has fluctuated within a day range of 138.00 to 143.00, while its 52-week range spans from 40.58 to 158.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.